Artisan Partners Limited Partnership Has $59.56 Million Stake in CME Group Inc. (NASDAQ:CME)

Artisan Partners Limited Partnership grew its stake in CME Group Inc. (NASDAQ:CMEGet Rating) by 2.4% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 290,957 shares of the financial services provider’s stock after purchasing an additional 6,697 shares during the period. Artisan Partners Limited Partnership owned about 0.08% of CME Group worth $59,559,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Massachusetts Financial Services Co. MA boosted its position in shares of CME Group by 132.0% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 3,382,773 shares of the financial services provider’s stock valued at $804,626,000 after acquiring an additional 1,924,772 shares in the last quarter. Capital International Investors boosted its position in shares of CME Group by 8.4% during the 1st quarter. Capital International Investors now owns 14,292,196 shares of the financial services provider’s stock valued at $3,400,650,000 after acquiring an additional 1,104,075 shares in the last quarter. TD Asset Management Inc. boosted its position in shares of CME Group by 224.1% during the 1st quarter. TD Asset Management Inc. now owns 992,012 shares of the financial services provider’s stock valued at $235,960,000 after acquiring an additional 685,884 shares in the last quarter. Lord Abbett & CO. LLC acquired a new stake in shares of CME Group during the 1st quarter valued at about $145,971,000. Finally, Vanguard Group Inc. lifted its holdings in CME Group by 1.6% during the 1st quarter. Vanguard Group Inc. now owns 31,847,850 shares of the financial services provider’s stock valued at $7,575,330,000 after purchasing an additional 490,885 shares during the last quarter. 85.56% of the stock is currently owned by institutional investors and hedge funds.

CME Group Trading Up 1.0 %

CME opened at $176.00 on Thursday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market cap of $63.31 billion, a price-to-earnings ratio of 23.95, a price-to-earnings-growth ratio of 2.81 and a beta of 0.41. The firm has a 50 day simple moving average of $176.11 and a 200 day simple moving average of $192.02. CME Group Inc. has a fifty-two week low of $166.58 and a fifty-two week high of $256.94.

CME Group (NASDAQ:CMEGet Rating) last issued its quarterly earnings data on Wednesday, October 26th. The financial services provider reported $1.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.93 by $0.05. The firm had revenue of $1.23 billion during the quarter, compared to analysts’ expectations of $1.23 billion. CME Group had a net margin of 54.01% and a return on equity of 10.06%. On average, sell-side analysts anticipate that CME Group Inc. will post 7.96 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 28th. Investors of record on Friday, December 9th will be issued a dividend of $1.00 per share. This represents a $4.00 dividend on an annualized basis and a yield of 2.27%. The ex-dividend date is Thursday, December 8th. CME Group’s dividend payout ratio is currently 54.42%.

Analysts Set New Price Targets

Several equities analysts recently issued reports on CME shares. Morgan Stanley cut their price target on shares of CME Group from $213.00 to $208.00 and set an “equal weight” rating for the company in a report on Thursday, October 27th. Raymond James downgraded shares of CME Group from an “outperform” rating to a “market perform” rating in a report on Monday, August 15th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of CME Group from $200.00 to $202.00 in a research note on Thursday, October 27th. Citigroup started coverage on shares of CME Group in a research note on Tuesday, October 11th. They issued a “buy” rating and a $220.00 target price for the company. Finally, Credit Suisse Group dropped their target price on shares of CME Group from $216.00 to $210.00 and set a “neutral” rating for the company in a research note on Tuesday, September 6th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and six have given a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $223.86.

Insider Activity at CME Group

In other news, Director Daniel R. Glickman sold 500 shares of the company’s stock in a transaction that occurred on Wednesday, August 31st. The shares were sold at an average price of $196.39, for a total value of $98,195.00. Following the completion of the transaction, the director now owns 14,597 shares in the company, valued at $2,866,704.83. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, Director William R. Shepard purchased 48,645 shares of CME Group stock in a transaction dated Friday, November 4th. The stock was bought at an average price of $170.00 per share, for a total transaction of $8,269,650.00. Following the completion of the acquisition, the director now directly owns 247,843 shares of the company’s stock, valued at $42,133,310. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Daniel R. Glickman sold 500 shares of the company’s stock in a transaction that occurred on Wednesday, August 31st. The shares were sold at an average price of $196.39, for a total transaction of $98,195.00. Following the completion of the transaction, the director now owns 14,597 shares of the company’s stock, valued at approximately $2,866,704.83. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 5,610 shares of company stock worth $1,123,970. 0.30% of the stock is currently owned by company insiders.

CME Group Company Profile

(Get Rating)

CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.

Further Reading

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.